CCA
PCRX icon

Catalyst Capital Advisors’s Pacira BioSciences PCRX Stock Holding History

Catalyst Capital Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-546
Closed -$42K – 383
2022
Q1 		$42K Buy
+546
New +$42K ﹤0.01% 319